(R)-2,2,2-Trifluoro-1-(4-fluorophenyl)ethanamine hydrochloride
95%
- Product Code: 37406
CAS:
1391504-83-8
| Molecular Weight: | 229.6000 g./mol | Molecular Formula: | C₈H₇NF₄HCl |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature |
Product Description:
This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). It is particularly significant in the development of drugs targeting central nervous system disorders, including antidepressants and antipsychotics. Its chiral structure makes it valuable for producing enantiomerically pure compounds, which are often essential for achieving desired therapeutic effects and minimizing side effects. Additionally, it is employed in research and development for exploring new pharmacological agents, especially those involving modulation of neurotransmitter systems. Its fluorine-containing structure also enhances metabolic stability and bioavailability of the resulting drugs.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | $867.00 |
+
-
|
(R)-2,2,2-Trifluoro-1-(4-fluorophenyl)ethanamine hydrochloride
This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). It is particularly significant in the development of drugs targeting central nervous system disorders, including antidepressants and antipsychotics. Its chiral structure makes it valuable for producing enantiomerically pure compounds, which are often essential for achieving desired therapeutic effects and minimizing side effects. Additionally, it is employed in research and development for exploring new pharmacological agents, especially those involving modulation of neurotransmitter systems. Its fluorine-containing structure also enhances metabolic stability and bioavailability of the resulting drugs.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :